TRANCE/RANKL plasma levels have also been reported lower in patients with nonalcoholic fatty liver disease (Nikseresht et al., 2020), a condition related to insulin resistance and obesity. Here, TNFSF11 is linked to obesity due to melanocortin 4 receptor deficiency.